These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 32391938)

  • 41. miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response.
    Hashemi M; Khosroshahi EM; Chegini MK; Abedi M; Matinahmadi A; Hosnarody YSD; Rezaei M; Saghari Y; Fattah E; Abdi S; Entezari M; Nabavi N; Rashidi M; Raesi R; Taheriazam A
    Pathol Res Pract; 2023 Nov; 251():154906. PubMed ID: 37939448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review.
    Deng Z; Wu J; Xu S; Chen F; Zhang Z; Jin A; Wang J
    Biomark Med; 2020 Feb; 14(2):141-150. PubMed ID: 32064893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
    Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exosomal miRNAs from highly metastatic cells can induce metastasis in non-metastatic cells.
    Kia V; Mortazavi Y; Paryan M; Biglari A; Mohammadi-Yeganeh S
    Life Sci; 2019 Mar; 220():162-168. PubMed ID: 30721706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exosomal microRNAs in the development of essential hypertension and its potential as biomarkers.
    Tan PPS; Hall D; Chilian WM; Chia YC; Mohd Zain S; Lim HM; Kumar DN; Ching SM; Low TY; Md Noh MF; Pung YF
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1486-H1497. PubMed ID: 33577433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors.
    Lässer C
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S189-97. PubMed ID: 22506888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exosomal microRNAs in lung cancer: a narrative review.
    Zhang Z; Lin F; Wu W; Jiang J; Zhang C; Qin D; Xu Z
    Transl Cancer Res; 2024 Jun; 13(6):3090-3105. PubMed ID: 38988916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ExomiRs: A Novel Strategy in Cancer Diagnosis and Therapy.
    Gorji-Bahri G; Hashemi A; Moghimi HR
    Curr Gene Ther; 2018; 18(6):336-350. PubMed ID: 30332956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
    Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
    Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exosomes: Potent regulators of tumor malignancy and potential bio-tools in clinical application.
    Guo L; Guo N
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):346-58. PubMed ID: 25982702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications.
    Cheng J; Meng J; Zhu L; Peng Y
    Mol Cancer; 2020 Mar; 19(1):66. PubMed ID: 32213181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNAs in extracellular vesicles: potential cancer biomarkers.
    Kinoshita T; Yip KW; Spence T; Liu FF
    J Hum Genet; 2017 Jan; 62(1):67-74. PubMed ID: 27383658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secretory microRNAs as biomarkers of cancer.
    Kai K; Dittmar RL; Sen S
    Semin Cell Dev Biol; 2018 Jun; 78():22-36. PubMed ID: 29258963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasis.
    Wang X; Luo G; Zhang K; Cao J; Huang C; Jiang T; Liu B; Su L; Qiu Z
    Cancer Res; 2018 Aug; 78(16):4586-4598. PubMed ID: 29880482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
    Wu M; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu Y; Jin H
    Life Sci; 2020 Aug; 255():117857. PubMed ID: 32470446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exosomal microRNAs and long noncoding RNAs: Novel mediators of drug resistance in lung cancer.
    Taghvimi S; Vakili O; Soltani Fard E; Khatami SH; Karami N; Taheri-Anganeh M; Salehi M; Negahdari B; Ghasemi H; Movahedpour A
    J Cell Physiol; 2022 Apr; 237(4):2095-2106. PubMed ID: 35128660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exosomal microRNA: a diagnostic marker for lung cancer.
    Rabinowits G; Gerçel-Taylor C; Day JM; Taylor DD; Kloecker GH
    Clin Lung Cancer; 2009 Jan; 10(1):42-6. PubMed ID: 19289371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
    Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases.
    Hwang S; Yang YM
    Arch Pharm Res; 2021 Jun; 44(6):574-587. PubMed ID: 34165701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
    Qin X; Yu S; Zhou L; Shi M; Hu Y; Xu X; Shen B; Liu S; Yan D; Feng J
    Int J Nanomedicine; 2017; 12():3721-3733. PubMed ID: 28553110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.